Page last updated: 2024-11-04

sotalol and Obstructive Lung Diseases

sotalol has been researched along with Obstructive Lung Diseases in 2 studies

Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Areskog, NH1
Cullhed, I1
Ringqvist, I1
Ström, G1
Kuntz, RE1
Ruskin, JN1
Weinberger, S1
Lorell, BH1

Other Studies

2 other studies available for sotalol and Obstructive Lung Diseases

ArticleYear
Cardiovascular and respiratory effects of the beta-adrenoceptive antagonist sotalol: studies in health, angina pectoris and obstructive lung disease.
    European journal of clinical pharmacology, 1975, Aug-14, Volume: 8, Issue:6

    Topics: Adult; Aged; Airway Resistance; Angina Pectoris; Blood Pressure; Chronic Disease; Exercise Test; Fem

1975
The advantage of d-sotalol over dl-sotalol in a patient with ventricular arrhythmias and comorbid bronchospasm.
    Chest, 1992, Volume: 102, Issue:5

    Topics: Bronchial Spasm; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Sotalol; Stereoisomerism; Sy

1992